Emerging treatments in Atopic Dermatitis (Eczema)

07 Jun 2022
06:30 PM - 07:30 PM


Available to
General Practitioners

Continuing Professional Development



Quality use of medicines
Quality improvement

This session will look at approaches and current recommendations in atopic dermatitis management. The speakers will also discuss updates on recent AD research and emerging therapies.

This education session is tailored for GPs hoping to find out more about current and upcoming treatments available for atopic dermatitis (AD) or eczema. AD is a common chronic inflammatory pruritic skin condition that affects approximately 1% of the Australian population and 20% of all Australian children. It may significantly impact the quality of life, sleep, mood, productivity and activities of daily living of affected individuals. 

With a wide range of clinical presentations, treatment must be tailored to the individual needs of the patient. While mild disease may be managed with patient education, irritant avoidance and general skin care measures, more severe cases may require topical anti-inflammatories including wet dressing, topical steroids and targeted therapies. 

Presented by the Dermatology Clinical Trial Department of Royal Melbourne Hospital, this event will look at approaches and current recommendations in AD management. The team will discuss updates on research in this field and emerging therapies as well as advanced targeted therapies now approved for use in Australia in patients with moderate to severe disease. 


A/Prof Johannes Kern is the author of over 60 articles in international peer-reviewed journals and recipient of multiple research awards. Interests: general dermatology (children and adults), skin cancer (including skin surgery), dermatopathology, autoimmune and blistering skin disease, pathology of the skin basement membrane, skin cancer-stroma interaction. Treatment, diagnosis, clinical trials and translational research

Dr Hnin Pwint Oo graduated from The University of Melbourne with a Doctor of Medicine in 2018. She has completed an internship and two years of residency prior to her current role as the Dermatology Clinical and Trials Fellow at The Royal Melbourne Hospital.

Dr Anthony Honigman graduated from Monash University with a Bachelor of Medicine and Surgery with Honours in 2017. His research work has previously been published in multiple journals and he is currently a Fellow in the Dermatology Clinical Trials Department at the Royal Melbourne Hospital. 

Learning outcomes:

By the end of this session, you will be able to:

  • Identify and utilise current therapies which are available including targeted therapies (biologics)
  • Discuss upcoming treatments and current clinical trials to treat AD with patients under your care
  • Demonstrate a thorough understanding of AD, clinical examination related to its diagnosis and current approaches to its management